
Elizabeth Stenger MD
Assistant Professor of Pediatrics, Emory University School of Medicine
Join to view full profile
1405 Clifton Road NEAtlanta, GA 30322
Dr. Stenger is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
UPMC Medical EducationFellowship, Pediatric Hematology/Oncology, 2009 - 2012
UPMC Medical EducationResidency, Pediatrics, 2006 - 2009
University of Pittsburgh School of MedicineClass of 2006
Certifications & Licensure
GA State Medical License 2013 - 2028
PA State Medical License 2009 - 2022
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Natural History Study of SCID Disorders Start of enrollment: 2010 Sep 02
- Patients Treated for SCID (1968-Present) Start of enrollment: 2011 May 15
- Bone Marrow Transplant With Abatacept for Non-Malignant Diseases
Publications & Presentations
PubMed
- Project Sickle Cure: A Prospective, International Observational Study of Hematopoietic Cell Transplantation for Sickle Cell Disease.Gregory M T Guilcher, Allistair Abraham, Staci D Arnold, Christine Camacho-Bydume, Jenny Duong
European Journal of Haematology. 2026-10-01 - Blood rheology after allogeneic hematopoietic stem cell transplantation or gene therapy in sickle cell disease.Ashwin P Patel, Tami D John, Stephen Gottschalk, Brandon M Triplett, Serena De Vita
Blood Advances. 2026-09-22 - Invasive Pneumococcal Disease After Hematopoietic Cell Transplantation for Sickle Cell Disease.Diego R Hijano, Caitlin Elgarten, Elizabeth Stenger, Katie Liu, Ann E Haight
Transplant Infectious Disease. 2026-07-07
Journal Articles
- Reduced Intensity Conditioning for Hematopoietic Cell Transplant for HLH and Primary Immune Deficiencies: BMT CTN 1204Shalini Shenoy, K Scott Baker, Elizabeth O Stenger, Carl Allen, Lauri Burroughs, Philip Roehrs, Catherine M Bollard, Rabi Hanna, Jeffrey R Andolina, James Connelly, Blood
Press Mentions
Progress Amid Ongoing Pain: ASH 2025 Studies Show Mixed Results in Sickle Cell DiseaseDecember 6th, 2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









